Retractable Technologies, Inc. (NYSE American: RVP) reported total net sales of $10.4 million for the second quarter of 2025, marking an increase from $6.0 million in the same period last year. Despite the rise in sales, the company experienced an operating loss of $5.1 million for the quarter, compared to a $5.8 million loss in the previous year. For the first half of the year, net sales reached $18.7 million, up from $13.6 million in 2024, while operating losses increased to $9.8 million from $8.7 million. The net loss for the three months ended June 30, 2025, was $87 thousand, while the net loss for the six months was $10.6 million, which included an unrealized net loss on third-party debt and equity investments totaling $5.6 million. The company also received a litigation settlement of $1.9 million during the second quarter. International revenues saw significant growth, with a 92.6% increase in the second quarter of 2025 compared to the same period in 2024. However, the average selling price per unit declined due to a shift in product mix and discounted sales of Easy Point Needles to certain international customers. Overall, unit sales increased by 109.2% in the quarter. The cost of manufactured products rose by 66.1%, largely due to increased tariffs and additional costs from heightened domestic production activities. Royalty expenses also grew by 39.4% due to the increase in gross sales, although this was slightly offset by a decrease in royalties payable under a sublicensing agreement. The company noted that there remains uncertainty regarding the timing of future international orders.